Bone Biologics Corporation (BBLG) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 4.98M | 5.8M | 6.35M | 7M | 3.16M | 3.86M | 4.07M | 3.19M | 3.84M | 3.74M | 4.98M | 7.62M | 6.78M | 8.5M | 5.2M | 5.66M | 6.09M | 6.68M | 52.39K | 4.44K |
| Cash & Short-Term Investments | 4.53M | 5.33M | 6.05M | 6.64M | 2.75M | 3.33M | 3.57M | 2.33M | 3.23M | 3.03M | 4.45M | 7.01M | 6.19M | 7.54M | 5.06M | 5.45M | 5.81M | 6.68M | 3.37K | 4.44K |
| Cash Only | 4.53M | 5.33M | 6.05M | 6.64M | 2.75M | 3.33M | 3.57M | 2.33M | 3.23M | 3.03M | 4.45M | 7.01M | 6.19M | 7.54M | 5.06M | 5.45M | 5.81M | 6.68M | 3.37K | 4.44K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 7.81K | 9.89K | 0 | 0 | 0 | 0 | 0 | 0 | 328.84K | 328.84K | 0 | 0 | 0 | 579.91K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -328.84K | -328.84K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 220.29K | 361.75K | 415.5K | 0 | 0 | 0 | 328.84K | 328.84K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.02K | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 4.98M | 5.8M | 6.35M | 7M | 3.16M | 3.86M | 4.07M | 3.19M | 3.84M | 3.74M | 4.98M | 7.62M | 6.78M | 8.5M | 5.2M | 5.66M | 6.09M | 6.68M | 52.39K | 4.44K |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 57.47% | 50.11% | 56.2% | 119.27% | -17.65% | 3.31% | -18.3% | -58.11% | -43.4% | -56% | -4.32% | 34.71% | 11.32% | 27.26% | 9826.85% | 127409.71% | 8462.8% | - | 2028.93% | 209.7% |
| Total Current Liabilities | 309.39K | 418.59K | 334.28K | 406.14K | 251.16K | 377.71K | 273.4K | 284.51K | 164.63K | 831.4K | 1.18M | 1.93M | 4.01M | 2.55M | 799.48K | 70.64K | 54.91K | 99.91K | 15.18M | 14.62M |
| Accounts Payable | 308.95K | 417.88K | 333.08K | 403.73K | 247.84K | 373.04K | 190.06K | 231.87K | 146.19K | 360.66K | 1.1M | 1.69M | 2.28M | 104.79K | 799.48K | 70.64K | 54.91K | 99.91K | 70.28K | 84.24K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.77M | 12.49M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44.98K | 0 | 0 | 0 | 0 | 0 | 783.67K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 438 | 703 | 1.2K | 2.41K | 3.31K | 4.67K | 83.34K | 7.66K | 18.44K | 470.74K | 80.51K | 241.16K | 1.73M | 1.66M | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 16.09x | 13.85x | 19.00x | 17.24x | 12.59x | 10.22x | 14.87x | 11.22x | 23.32x | 4.50x | 4.21x | 3.95x | 1.69x | 3.33x | 6.51x | 80.11x | 110.97x | 66.81x | 0.00x | 0.00x |
| Quick Ratio | 16.09x | 13.85x | 19.00x | 17.24x | 12.59x | 10.22x | 14.87x | 11.22x | 25.32x | 4.89x | 4.21x | 3.95x | 1.69x | 3.33x | 6.51x | 80.11x | 110.97x | 66.81x | 0.00x | 0.00x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.41M | 2.13M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.41M | 2.13M |
| Total Liabilities | 309.39K | 418.59K | 334.28K | 406.14K | 251.16K | 377.71K | 273.4K | 284.51K | 164.63K | 831.4K | 1.18M | 1.93M | 4.01M | 2.55M | 799.48K | 70.64K | 54.91K | 99.91K | 15.18M | 14.62M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.77M | 12.49M |
| Net Debt | -4.53M | -5.33M | -6.05M | -6.64M | -2.75M | -3.33M | -3.57M | -2.33M | -3.23M | -3.03M | -4.45M | -7.01M | -6.19M | -7.54M | -5.06M | -5.45M | -5.81M | -6.68M | 12.76M | 12.49M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | -4.64x | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.22x | - | - | - | -10.94x | -0.82x | -0.89x |
| Total Equity | 4.67M | 5.38M | 6.02M | 6.6M | 2.91M | 3.48M | 3.79M | 2.91M | 3.67M | 2.91M | 3.79M | 5.69M | 2.77M | 5.95M | 4.4M | 5.59M | 6.04M | 6.58M | -15.13M | -14.62M |
| Equity Growth % | 60.43% | 54.36% | 58.65% | 126.75% | -20.79% | 19.86% | -0.02% | -48.9% | 32.55% | -51.13% | -13.82% | 1.87% | -54.09% | -9.55% | 129.1% | 138.23% | 142.76% | 148.02% | -14.25% | -13.79% |
| Book Value per Share | 2.60 | 4.58 | 3.35 | 11.83 | 0.91 | 1.18 | 2.16 | 2.49 | 5.56 | 6.33 | 9.68 | 16.78 | 41.25 | 97.39 | 101.91 | 129.58 | 140.02 | 152.47 | -295.77 | -285.81 |
| Total Shareholders' Equity | 4.67M | 5.38M | 6.02M | 6.6M | 2.91M | 3.48M | 3.79M | 2.91M | 3.67M | 2.91M | 3.79M | 5.69M | 2.77M | 5.95M | 4.4M | 5.59M | 6.04M | 6.58M | -15.13M | -14.62M |
| Common Stock | 1.79K | 1.79K | 1.79K | 1.69K | 3.27K | 2.95K | 2.1K | 1.31K | 1.02K | 534 | 3.13K | 3.13K | 16.7K | 15.3K | 10.35K | 10.35K | 10.35K | 10.35K | 12.27K | 30.68K |
| Retained Earnings | -88.9M | -88.13M | -87.45M | -86.78M | -86.04M | -85.02M | -83.5M | -82.56M | -81.77M | -80.91M | -79.36M | -77.44M | -75.67M | -71.96M | -72.85M | -71.63M | -71.17M | -70.48M | -70.3M | -69.79M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |